Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

St. Petersburg Times Examines Work Of Paul Farmer, Potential Candidate For USAID, State Department Position
The St. Petersburg Times examines the work of Paul Farmer - "the Harvard-educated doctor who, starting in Haiti, built a multinational organization on the radical idea that poor patients deserve the same care as rich ones" and is reportedly being considered for a high-level job with USAID or the State Department. The newspaper reports that though it"s "not a sure thing, even his candidacy indicates how far the international aid establishment has come around to Farmer"s way of thinking, health care experts say."
generic viagra online
Ex-Senate Leaders Craft Bipartisan Health Care Compromise
"Democrats Tom Daschle and George Mitchell are set to join Republicans Bob Dole and Howard Baker on Wednesday to release a $1.2 trillion proposal that would be fully paid for with a combination of spending cuts and tax increases," the Associated Press reports. The proposal from the four former Senate leaders "combines ideas from both political parties to guarantee coverage for all" and is an attempt to "prevent a repeat of the 1990s standoff over health care."
News of the day
HIV/AIDS Research Efforts Of New York Scientist Featured
The Brook Community Newspapers/Connecticut Post profiled New York researcher Jeffrey Laurence, who "helped at the outset to fully identify" HIV along with French virologist Luc Antoine Montagnier and others. Laurence, now of the Weill Cornell Medical College Laboratory for AIDS Virus Research at the New York Blood Center, in 1984, "published a paper with Montagnier in the New England Journal of Medicine that brought the news that their virus was the cause of AIDS," the article states. Since the discovery Laurence has continued his research seeking to develop a cure or vaccine for the virus, which now includes investigating the role of stem cells. He said, "The technology is too young to try to say we can cure someone of AIDS or of cancer. We need money to know how to engineer, to refine stem cells to be resistant to infection." The article states, "Laurence is pleased however, that President Barack Obama is "kinder on stem cells and is releasing some of the restrictions,"" on stem cell research (Semmes, 7/24).
Nutrition

Sepracor Pharmaceuticals Ltd Withdraws Its Marketing Authorisation Application For Lunivia (eszopiclone)

The European Medicines Agency has been formally notified by Sepracor Pharmaceuticals Ltd of its decision to withdraw its application for a centralised marketing authorisation for the medicine Lunivia (eszopiclone), 2 and 3 mg tablets. Lunivia was expected to be used for the treatment of insomnia, including difficulty falling asleep, nocturnal awakening or early awakening in adults, usually for short-term duration. The application for the marketing authorisation for Lunivia was submitted to the Agency on 23 July 2007. In October 2008, Lunivia received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP), recommending that the medicine be granted a marketing authorisation. However, the CHMP recommended that the medicine should not be granted "new active substance" status. Following a re÷¬examination procedure at the request of the applicant, the CHMP confirmed its previous opinion in February 2009. At the time of withdrawal, the application was pending the adoption of a marketing authorisation decision by the European Commission. In its official letter, the company stated that the withdrawal of the application was based on the CHMP"s recommendation that Lunivia should not be regarded as containing a new active substance, and that the commercial viability of launching the product in the European Union was compromised. More information about Lunivia and the state of the scientific assessment at the time of withdrawal will be made available in a question-and-answer document. This document, together with the withdrawal letter from the company, will be published on the Agency"s website after the next CHMP meeting of 26-29 May 2009. Notes 1. Withdrawal of an application does not prejudice the possibility of a company making a new application at a later stage. 2. The press release from the October 2008 meeting can be found here. 3. The summary of the positive opinion from October 2008 can be found here. EMEA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009